Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




Kaj Blennow

Professor/ chief physician

Kaj Blennow
Professor/ chief physician
kaj.blennow@clinchem.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Laborativ neurovetenskap , Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Kaj Blennow

Latest publications

Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
C. Meregalli, G. Fumagalli, P. Alberti, A. Canta, A. Chiorazzi et al.
Archives of Toxicology, Journal article 2020
Journal article

A beta deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
N. Mattsson-Carlgren, E. Andersson, S. Janelidze, R. Ossenkoppele, P. Insel et al.
Science Advances, Journal article 2020
Journal article

Longitudinal change in regional brain volumes with exposure to repetitive head impacts.
Charles Bernick, Guogen Shan, Henrik Zetterberg, Sarah Banks, Virendra R Mishra et al.
Neurology, Journal article 2020
Journal article

Neurofilament-Light in Former Athletes: A Potential Biomarker of Neurodegeneration and Progression.
Foad Taghdiri, Namita Multani, Miracle Ozzoude, Apameh Tarazi, Mozhgan Khodadadi et al.
European journal of neurology, Journal article 2020
Journal article

Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Hailey A Kresge, Dandan Liu, Deepak K Gupta, Elizabeth E Moore, Katie E Osborn et al.
Journal of Alzheimer's disease : JAD, Journal article 2020
Journal article

Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
N. Falgas, M. Ruiz-Peris, A. Perez-Millan, R. Sala-Llonch, A. Antonell et al.
Human Brain Mapping, Journal article 2020
Journal article

Neuroinflammatory markers associate with cognitive decline after major surgery: Findings of an explorative study
Mattias Danielson, A. Wiklund, F. Granath, Kaj Blennow, S. Mkrtchian et al.
Annals of Neurology, Journal article 2020
Journal article

Showing 11 - 20 of 1177

2020

Low CSF/serum ratio of free T4 is associated with decreased quality of life in mild hypothyroidism - A pilot study.
Anders Funkquist, Anders Bengtsson, Per Johansson, Johan Svensson, Per Bjellerup et al.
Journal of clinical & translational endocrinology, Journal article 2020
Journal article

Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Pawel Obrocki, Ayesha Khatun, Deborah Ness, Konstantin Senkevich, Jörg Hanrieder et al.
Alzheimer's research & therapy, Review article 2020
Review article

Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration
E. H. Thijssen, R. La Joie, A. Wolf, A. Strom, P. Wang et al.
Nature Medicine, Journal article 2020
Journal article

An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
Nicholas J. Ashton, Abdul Hye, Anto P Rajkumar, Antoine Leuzy, Stuart Snowden et al.
Nature Reviews Neurology, Review article 2020
Review article

The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
Martí Colom-Cadena, Tara Spires-Jones, Henrik Zetterberg, Kaj Blennow, Anthony Caggiano et al.
Alzheimer's research & therapy, Journal article 2020
Journal article

Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia.
Franc Llorens, Peter Hermann, Anna Villar-Piqué, Daniela Diaz-Lucena, Katarina Nägga et al.
Nature communications, Journal article 2020
Journal article

Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Sven J van der Lee, Olivia J Conway, Iris Jansen, Minerva M Carrasquillo, Luca Kleineidam et al.
Acta neuropathologica, Journal article 2020
Journal article

Showing 11 - 20 of 1177

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?